Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (10397)	6/7/2018 12:04:49 AM
From: cacmed	Read Replies (3) \| Respond to of 12871

But the knowledge does not go away because NNVC goes away. As I suggested a big pharma could simply buy the lab at the NNVC bankruptcy auction and then enter into an agreement with Theracure to continue the work. The relationship with Anil would be a lot more restrictive from his point of view in that he would retain some of his patent rights under a new contractual agreement but no corporation would repeat the convoluted deal he has set up with NNVC. At that point we no longer exist in the equation. Anil continues exactly as he is now and the pharma puts their own people into the lab to verify his results. Money to take the effort forward is no concern and pharma has one person to deal with. The cost of the lab purchase and the first two or three years of salaries would be chump change. Everything is the same except that we are no longer in the game. I bought BIND right after they announced successful results from Phase testing and that they had received a monetary package from big pharma. The next month they declared bankruptcy. I have received three partial payment checks from some attorney in L.A., who won't even acknowledge what I am receiving the checks for and won't respond to any attempts at contact. I have received about 20% of my investment. The checks come under some fund name that doesn't even mention BIND.